A preparation method of giant magnetically responsive drug-loaded vesicles with targeting function
A magnetically responsive and functional technology, applied in the field of preparation of drug-loaded vesicles, can solve the problems of poor cell killing selectivity, poor tumor tissue targeting, and large toxic and side effects, and achieves easy separation and purification, large drug-loading capacity, Simple to use effects
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
specific Embodiment approach 1
[0024] Embodiment 1: This embodiment is a method for preparing giant magnetically responsive drug-loaded vesicles with targeting function, which is specifically prepared according to the following steps:
[0025] 1. Preparation of phospholipid solution: Dissolve negatively charged phospholipids and neutral phospholipids in chloroform to obtain a phospholipid solution with a total phospholipid concentration of 1-20 mg / mL;
[0026] The total phospholipid concentration described in step 1 is that the mass ratio of negatively charged phospholipids and neutral phospholipids in the phospholipid solution of 1 to 20 mg / mL is (0.005 to 0.2): 1;
[0027] The negatively charged phospholipid described in step 1 is phosphatidylethanolamine phospholipid or fluorescent ethanolamine phospholipid;
[0028] The neutral phospholipid described in step 1 is a choline phospholipid;
[0029] 2. Apply the phospholipid solution with a total phospholipid concentration of 1 to 20 mg / mL obtained in step...
specific Embodiment approach 2
[0040] Embodiment 2: The difference between this embodiment and Embodiment 1 is that the phosphatidylethanolamine phospholipid described in step 1 is dioleoylphosphatidylethanolamine; the fluorescently labeled ethanolamine phospholipid is TR-DHPE or NBD-PE. Others are the same as the first embodiment.
specific Embodiment approach 3
[0041] Specific embodiment three: the difference between this embodiment and specific embodiment one or two is: the neutral phospholipid described in step one is choline phospholipid; Alkaline, egg yolk lecithin, dimyristoylphosphatidylcholine or dipalmitoylphosphatidylcholine. Others are the same as those in Embodiment 1 or 2.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com